Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.4 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |